BLRX · Bioline Rx Ltd ADR
United States · RS rating 17 · As of 2026-11-03
| Price | 1.91 USD |
|---|---|
| 1-day change | -2.5% |
| RS rating (overall / 1M / 3M / 12M) | 17 / 24 / 21 / 24 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 16 / 6 / 17 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -54.6% |
| Distance from 52-week high | +49.5% |
| Market cap (USD) | $10.3M |